Lindsay K. Burdette

Lindsay K. Burdette serves as a key procurement professional within the Naval Medical Logistics Command, supporting the Department of Defense’s mission to sustain combat-ready medical forces through the acquisition of critical diagnostic, life-sustaining, and point-of-care medical systems. Responsible for managing complex contractual actions across global operational theaters, Burdette specializes in securing in-vitro diagnostic substances, advanced clinical equipment, and technical consulting services essential to naval and marine corps medical readiness. Her acquisitions directly enable frontline medical response, preventive care, and diagnostic precision in austere environments, aligning with the Command’s strategic priorities in modernizing field-deployable medical capabilities. While specific contractor names are not publicly disclosed, Burdette maintains a robust network of vendors specializing in medical diagnostics, clinical imaging, and scientific technical services. Her contracting patterns reflect a preference for established suppliers with proven expertise in FDA-regulated medical products and defense-compliant supply chains, often engaging firms capable of rapid logistics support and compliance with MIL-STD and DoD acquisition regulations. Her working relationships emphasize reliability, technical compliance, and supply chain resilience over volume-based procurement. Burdette demonstrates a strong commitment to small business participation, with 21.7% of her acquisitions structured as total small business set-asides under FAR 19.5. Though no specific socioeconomic categories like 8(a), HUBZone, or SDVOSB are dominant, her portfolio consistently creates pathways for qualified small businesses to compete for medical logistics contracts, reinforcing DoD’s broader socioeconomic goals while maintaining mission-critical performance standards. Her primary procurement focus centers on NAICS 325413 (in-vitro diagnostic substance manufacturing), with significant activity in diagnostic imaging centers (621512) and scientific consulting services (541690). She routinely procures laboratory reagents, portable diagnostic kits, imaging system components, and technical support for clinical deployment—reflecting deep expertise in medical technology lifecycle management and field-adaptable healthcare solutions.